2020
DOI: 10.2147/dddt.s245847
|View full text |Cite
|
Sign up to set email alerts
|

<p>Emodin Retarded Renal Fibrosis Through Regulating HGF and TGFβ–Smad Signaling Pathway</p>

Abstract: Background: Renal fibrosis is a frequently occurring type of chronic kidney disease that can cause end-stage renal disease. It has been verified that emodin or HGF can inhibit the development of renal fibrosis. However, the antifibrotic effect of emodin in combination with HGF remains unclear. Methods: Cell viability was detected with CCK8. Gene and protein expression in HK2 cells was detected by qRT-PCR and Western blot, respectively. Moreover, a unilateral ureteral obstruction-induced mouse model of renal fi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 46 publications
0
10
0
Order By: Relevance
“…Although rhein has been widely demonstrated to protect against renal fibrosis ( Zeng et al, 2014 ; Hu et al, 2019 ; He et al, 2020 ; Wu et al, 2020 ; Yu et al, 2020 ), only two previous studies have reported that rhein protected against renal fibrosis by inhibiting the NF-ƙB p65 protein expression ( Liu et al, 2021b ) and lincRNA-COX2/miR-150-5p/STAT1 axis ( Hu et al, 2020b ). Similarly, a number of publications have demonstrated that emodin retarded renal fibrosis by modulating several pathways, such as TGF-β/Smad, TGF-β/BMP-7, PI3K/Akt/GSK-3β, and Bax/caspase-3 signaling pathways ( Jing et al, 2017 ; Ma et al, 2018b ; Yang et al, 2020 ; Liu et al, 2021c ). Furthermore, several studies have demonstrated the inhibitory effect of emodin on renal fibrosis by suppressing the NF-ƙB p65 protein expression ( Lu et al, 2020 ) or the levels of ROS, TNF-α, and interleukin-6 ( Chen et al, 2017c ; Jing et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Although rhein has been widely demonstrated to protect against renal fibrosis ( Zeng et al, 2014 ; Hu et al, 2019 ; He et al, 2020 ; Wu et al, 2020 ; Yu et al, 2020 ), only two previous studies have reported that rhein protected against renal fibrosis by inhibiting the NF-ƙB p65 protein expression ( Liu et al, 2021b ) and lincRNA-COX2/miR-150-5p/STAT1 axis ( Hu et al, 2020b ). Similarly, a number of publications have demonstrated that emodin retarded renal fibrosis by modulating several pathways, such as TGF-β/Smad, TGF-β/BMP-7, PI3K/Akt/GSK-3β, and Bax/caspase-3 signaling pathways ( Jing et al, 2017 ; Ma et al, 2018b ; Yang et al, 2020 ; Liu et al, 2021c ). Furthermore, several studies have demonstrated the inhibitory effect of emodin on renal fibrosis by suppressing the NF-ƙB p65 protein expression ( Lu et al, 2020 ) or the levels of ROS, TNF-α, and interleukin-6 ( Chen et al, 2017c ; Jing et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…When emodin was used in combination with HGF, the expression of TGF-β1 in UUO mice and in HK2 cells was decreased. This indicates that the combined use of HGF and emodin can inhibit renal fibrosis by inhibiting the TGF-β/Smad signaling pathway, and the effect is better than that of emodin alone ( Yang et al, 2020 ). Yang et al confirmed that emodin can inhibit the expression of TGF-β1 and FN by inhibiting the NF-κB signaling pathway ( Yang et al, 2013 ).…”
Section: Inhibitory Effects Of the Natural Ingredients On Renal Fibrosismentioning
confidence: 99%
“…Results from both in vivo and in vitro experiments have revealed that emodin has biological properties, such as antibacterial [ 10 ], anti-inflammatory [ 11 ], antiulcer [ 12 ], and immunosuppressive [ 13 ] activities. Furthermore, emodin can be used to treat renal fibrosis [ 14 ]. Emodin has been extensively investigated in studies on kidney diseases, such as diabetic nephropathy [ 15 ], renal fibrosis [ 16 ], and AKI.…”
Section: Introductionmentioning
confidence: 99%